Legal Representation
Attorney
Fabio Silva
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 27, 2019 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Aug 27, 2019 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Aug 27, 2019 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Feb 10, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 10, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 10, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jan 27, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 29, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 20, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Reagents and kits comprising reagents for scientific or research use and for clinical or medical laboratory use in connection with cell manipulation, cell transformation, genomic editing and genomic editing analysis
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Reagents and kits comprising reagents for medical use in connection with cell manipulation, cell transformation, genomic editing and genomic editing analysis
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical apparatus and instruments used in the manipulation of cells and the introduction of nucleic acids and genome edits
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and medical research services in the fields of cell transformation, genome editing and analysis of cells, proteins, nucleic acids and other biological molecules; software for performance and analysis of genome editing of cells
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
010
042